Cancer Research AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 5528-5530, December 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tachibana, O.
Right arrow Articles by Ohgaki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tachibana, O.
Right arrow Articles by Ohgaki, H.

Expression of Fas/APO-1 during the Progression of Astrocytomas

Osamu Tachibana, Hisayoshi Nakazawa, Johannes Lampe, Kunihiko Watanabe, Paul Kleihues and Hiroko Ohgaki1

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon, Cedex 08, France [O. T., H. N., K. W., P. K., H. O.], and Institute of Neuropathology, University Hospital, 8091 Zürich, Switzerland [J. L., P. K.]

Fas/APO-1 (CD95) is an apoptosis-signaling receptor molecule on the surface of cells. To investigate the possible role of Fas during malignant transformation of glial cells, we analyzed the expression of Fas mRNA by reverse transcription-PCR in human astrocytic brain tumors. Expression was found in 1 of 4 (25%) juvenile pilocytic astrocytomas (WHO grade I), 1 of 9 (11%) low-grade astrocytomas (WHO grade II), 6 of 12 (50%) anaplastic astrocytomas (WHO grade III), and all of 9 glioblastomas (WHO grade IV). Thus, the frequency of Fas expression appears to correlate with the malignancy grade of astrocytomas. The soluble form of the Fas mRNA lacking the transmembrane domain was detected in one anaplastic astrocytoma and in two glioblastomas.

1 To whom requests for reprints should be addressed, at Unit of Molecular Pathology, IARC, 150 cours Albert Thomas, 69372 Lyon, Cedex 08, France. Phone: 33 72 73 85 34; Fax: 33 72 73 85 64.

Received 9/ 5/95. Accepted 10/19/95.




This article has been cited by other articles:


Home page
Biol. Reprod.Home page
B. Selam, U. A. Kayisli, G. E. Akbas, M. Basar, and A. Arici
Regulation of FAS Ligand Expression by Chemokine Ligand 2 in Human Endometrial Cells
Biol Reprod, August 1, 2006; 75(2): 203 - 209.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Xia, E. M. Rosen, and J. Laterra
Sensitization of Glioma Cells to Fas-Dependent Apoptosis by Chemotherapy-Induced Oxidative Stress
Cancer Res., June 15, 2005; 65(12): 5248 - 5255.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Chahlavi, P. Rayman, A. L. Richmond, K. Biswas, R. Zhang, M. Vogelbaum, C. Tannenbaum, G. Barnett, and J. H. Finke
Glioblastomas Induce T-Lymphocyte Death by Two Distinct Pathways Involving Gangliosides and CD70
Cancer Res., June 15, 2005; 65(12): 5428 - 5438.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Selam, U. A. Kayisli, J. A. Garcia-Velasco, G. E. Akbas, and A. Arici
Regulation of Fas Ligand Expression by IL-8 in Human Endometrium
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3921 - 3927.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
C. D. Riffkin, A. Z. Gray, C. J. Hawkins, C.W. Chow, and D. M. Ashley
Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction
Neuro-oncol, October 1, 2001; 3(4): 229 - 240.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
B. Selam, U. A. Kayisli, N. Mulayim, and A. Arici
Regulation of Fas Ligand Expression by Estradiol and Progesterone in Human Endometrium
Biol Reprod, October 1, 2001; 65(4): 979 - 985.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Weisberg, E. Ashkenazi, Z. Israel, M. Attia, Y. Shoshan, F. Umansky, and C. Brodie
Anaplastic and Atypical Meningiomas Express High Levels of Fas and Undergo Apoptosis in Response to Fas Ligation
Am. J. Pathol., October 1, 2001; 159(4): 1193 - 1197.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
W. Roth, S. Isenmann, M. Nakamura, M. Platten, W. Wick, P. Kleihues, M. Bähr, H. Ohgaki, A. Ashkenazi, and M. Weller
Soluble Decoy Receptor 3 Is Expressed by Malignant Gliomas and Suppresses CD95 Ligand-induced Apoptosis and Chemotaxis
Cancer Res., March 1, 2001; 61(6): 2759 - 2765.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Wick, C. Grimmel, B. Wagenknecht, J. Dichgans, and M. Weller
Betulinic Acid-Induced Apoptosis in Glioma Cells: A Sequential Requirement for New Protein Synthesis, Formation of Reactive Oxygen Species, and Caspase Processing
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1306 - 1312.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
T. Sawa, F. Nishimura, H. Ohyama, K. Takahashi, S. Takashiba, and Y. Murayama
In Vitro Induction of Activation-Induced Cell Death in Lymphocytes from Chronic Periodontal Lesions by Exogenous Fas Ligand
Infect. Immun., March 1, 1999; 67(3): 1450 - 1454.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Z. F. Cheema, S. B. Wade, M. Sata, K. Walsh, F. Sohrabji, and R. C. Miranda
Fas/Apo [Apoptosis]-1 and Associated Proteins in the Differentiating Cerebral Cortex: Induction of Caspase-Dependent Cell Death and Activation of NF-kappa B
J. Neurosci., March 1, 1999; 19(5): 1754 - 1770.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Runic, C. J. Lockwood, L. LaChapelle, B. Dipasquale, R. I. Demopoulos, A. Kumar, and S. Guller
Apoptosis and Fas Expression in Human Fetal Membranes
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 660 - 666.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Li, Y. Ueda, B. Shi, L. Borodyansky, L. Huang, Y.-Z. Li, and A. B. Pardee
Tat protein induces self-perpetuating permissivity for productive HIV-1 infection
PNAS, July 22, 1997; 94(15): 8116 - 8120.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.